Cybernet Data Systems Inc.
At the 2022 annual meeting of stockholders of ServiceSource International, Inc. (the "Company") held on May 12, 2022, stockholders voted on several proposals. A total of 87,415,894 shares of common stock, representing 87.5% of the outstanding shares entitled to vote, were represented at the meeting.
Cybernet Data Systems Inc.
We are a commercial-stage biopharmaceutical company with a strategic focus on in-licensing and developing products that treat rare diseases, especially those in the neuromuscular and neurological spaces. However, following a 2021 decision to broaden and diversify our product portfolio, we have been actively exploring opportunities to acquire companies with drug
Cybernet Data Systems Inc.
Community Trust Bancorp, Inc., a bank holding company headquartered in Pikeville, Kentucky, reported earnings for the first quarter 2022 of $19.7 million, or $1.11 per basic share. This represents a decrease from the first quarter 2021 earnings of $23.6 million, or $1.33 per basic share. The
Cybernet Data Systems Inc.
SpartanNash Company, a food solutions provider, has issued a statement responding to claims made by Macellum Advisors GP, LLC and Ancora Holdings Group, LLC. The investor group had issued a press release accusing SpartanNash's Chair of the Board and CEO of not responding to their outreach, which the
Cybernet Data Systems Inc.
Momentus Inc., a U.S. commercial space company, has announced that it has received a license from the Federal Communications Commission (FCC) supporting the inaugural flight of the Vigoride orbital transfer vehicle on the upcoming SpaceX Transporter-5 mission targeted for launch in May 2022. This milestone marks a significant step
Cybernet Data Systems Inc.
General Dynamics, a global aerospace and defense company, reported strong first-quarter 2022 financial results, exceeding expectations with net earnings of $730 million on revenue of $9.4 billion. The company achieved a 5.2% increase in diluted earnings per share (EPS) to $2.61, driven by continued strong demand for
Cybernet Data Systems Inc.
Whirlpool Corporation, a global kitchen and laundry company, reported solid first-quarter GAAP and ongoing earnings despite a revenue decline caused by a temporary slowdown primarily driven by ongoing supply disruptions. The company's net earnings available to Whirlpool were $313 million (net earnings margin of 6.4%), or $5.
Cybernet Data Systems Inc.
Heather Hasson, Co-CEO and Co-Founder of FIGS, Inc., announced the appointment of three new independent directors to the company's Board: A.G. Lafley, Kenneth Lin, and Jeffrey Wilke. The new directors will bring extensive experience in public company leadership, technology, e-commerce, and operations to the Board. Lafley, Lin,
Cybernet Data Systems Inc.
Macy's, Inc. has strengthened its board of directors with the addition of Marie Chandoha and Jill Granoff, effective April 1, 2022. Both appointees bring extensive leadership experience and expertise in finance, investment management, and retail. Chandoha's background in financial services and capital markets will complement Macy&
Information technology services industry
ACCO Brands Corporation, a leading manufacturer of academic, consumer, and business products, has announced the appointment of Deborah A. O'Connor as Executive Vice President and Chief Financial Officer, effective April 4, 2022. O'Connor will succeed Neal V. Fenwick, who will retire in August 2022 after a
Information technology services industry
Astra Space, Inc. and Spaceflight Inc. have entered into a multi-launch contract, providing Spaceflight with launch opportunities using Astra's launch services through 2025. The first launch under this contract is scheduled for March 14, 2022, with a window opening at 9:22am PDT / 16:22 UTC out of
Cybernet Data Systems Inc.
AbCellera's bebtelovimab, a monoclonal antibody therapy, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the treatment of mild-to-moderate COVID-19. Developed in collaboration with Eli Lilly and Company, bebtelovimab is authorized for use in adults and pediatric patients 12 years of
